Miller-Rich Nancy

CIK 00017350844 companiesEMERYVILLE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001735084

Recent Transactions

43 trades

Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2025-06-17+22,500→ 22,500 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2025-06-10+62,728→ 62,728 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2025-06-10+2,413→ 2,413 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2024-06-04+1,736→ 1,736 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2024-06-04+40,282→ 40,282 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right To Buy)
2024-05-21+22,500→ 22,500 total
Disposition from Tender
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−22,304→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,174→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,790→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−7,684→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−2,966→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,547→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-11-08−12,089→ 0 total
Disposition to Issuer
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-11-08$19.00/sh−8,111→ 0 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2023-06-30+915→ 915 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2023-06-30+21,222→ 21,222 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2023-05-24+12,547→ 12,547 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2023-05-24+8,111→ 30,415 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2023-05-23+22,500→ 22,500 total
Purchase
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2023-04-12$10.13/sh+509→ 922 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2022-06-07+53,812→ 53,812 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2022-06-07+2,319→ 2,319 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2022-05-25+7,737→ 22,304 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2022-05-25+12,790→ 12,790 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2022-05-23+22,500→ 22,500 total
Disposition to Issuer
Kadmon Holdings, Inc.
Stock Option (right to buy)
2021-11-09$5.92/sh−96,975→ 0 total
Disposition to Issuer
Kadmon Holdings, Inc.
Stock Option (right to buy)
2021-11-09$5.33/sh−36,364→ 0 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2021-06-08+583→ 583 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2021-06-08+13,534→ 13,534 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2021-05-27+7,029→ 14,567 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2021-05-27+12,089→ 12,089 total
Award
4D Molecular Therapeutics, Inc.$FDMT
Stock Option (Right to Buy)
2021-05-17+22,500→ 22,500 total
Award
Kadmon Holdings, Inc.
Stock Option (right to buy)
2021-05-12+96,975→ 96,975 total
Purchase
Aldeyra Therapeutics, Inc.$ALDX
Common Stock
2021-05-03$12.81/sh+413→ 413 total
Award
Kadmon Holdings, Inc.
Stock Option (right to buy)
2020-08-13$4.17/sh+36,364→ 36,364 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2020-06-09+26,503→ 26,503 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2020-05-28+1,595→ 7,538 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2020-05-28+2,966→ 2,966 total
Award
Aldeyra Therapeutics, Inc.$ALDX
Stock Option (Right to Buy)
2020-01-13+24,264→ 24,264 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2019-06-20+2,174→ 2,174 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2019-06-20+1,570→ 5,943 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Option to Purchase Common Stock
2018-06-20+7,684→ 7,684 total
Award
INTERCEPT PHARMACEUTICALS, INC.
Common Stock
2018-06-20+4,373→ 4,373 total

Companies

Recent Filings

Address

C/O 4D MOLECULAR THERAPEUTICS, INC. 5858 HORTON STREET #455

EMERYVILLE, CA, 94608

View on SEC.gov